Cardiac Syndromes in Liver Disease: A Clinical Conundrum

Milos Brankovic1,2, Paul Lee1, Nikolaos Pyrsopoulos3

  • 1Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

Insights

Cardio-hepatic interactions are complex and bidirectional, impacting patients with heart and liver disease. Optimizing cardiac function is key to treating conditions like congestive hepatopathy and cardiogenic liver injury.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cardio-hepatic interactions are bidirectional and challenging to manage.
  • Conditions like congestive hepatopathy and acute cardiogenic liver injury arise from cardiac dysfunction.
  • Advanced liver disease can lead to cardiac complications like cirrhotic cardiomyopathy and hyperdynamic syndrome.

Purpose of the Study:

  • To provide an overview of cardiac syndromes in liver disease.
  • To discuss the challenges in identifying, assessing, and treating cardio-hepatic interactions.
  • To explore current treatment options and future perspectives for these conditions.

Main Methods:

  • Literature review of studies on cardio-hepatic interactions.
  • Analysis of conditions such as congestive hepatopathy, acute cardiogenic liver injury, and cirrhotic cardiomyopathy.
  • Discussion of complications like hepatopulmonary syndrome and portopulmonary hypertension.

Main Results:

  • Cardio-hepatic interactions are bidirectional, with cardiac issues impacting the liver and vice versa.
  • Congestive hepatopathy and acute cardiogenic liver injury require optimization of cardiac function for treatment.
  • Liver disease can precipitate various cardiac syndromes, complicating patient management and liver transplantation eligibility.

Conclusions:

  • Effective management of patients with co-existing heart and liver conditions necessitates a thorough understanding of their intricate interactions.
  • Addressing cardiac dysfunction is crucial for treating liver-related cardiac complications.
  • Further research is needed to refine treatment strategies for these complex cases, especially concerning anticoagulation and statin use in liver disease patients.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
669
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
24
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
19
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K